Immunotherapy Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Immunotherapy Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Creutzfeldt-Jakob Disease
Research data from Mayo Clinic, Medical Department update understanding of Creutzfeldt-Jakob disease
November 26th, 2008
According to recent research from the United States, "Rapidly progressive dementia has a variety of causes, including Creutzfeldt-Jakob disease (CJD) and neuronal voltage-gated potassium channel (VGKC) autoantibody-associated encephalopathy. To describe patients thought initially to have CJD but found subsequently to have immunotherapy-responsive VGKC autoimmunity." "Observational, prospective case series. Department of Neurology, Mayo Clinic, and the Memory and Aging Center, University of California, San Francisco. A clinical serologic cohort of 15 patients referred for paraneoplastic autoantibody evaluation. Seven patients were evaluated clinically by at least one of...
Source: Immunotherapy Weekly (2008-11-26)
|
